Not Yet RecruitingACTRN12618002059246
Official study titleAcceptability of a new online self-management tool (WAKA) for people living with
schizophrenia who are prescribed paliperidone injection
This study isn't recruiting yet.
In New ZealandSchizophreniaInterventional studyAges 18–65
- Countries
- New Zealand
- Sponsor
- Dr Lyndy Matthews
Not Yet RecruitingACTRN12626001211358
Official study titleAn open label study to evaluate the tolerability of 14-day self-administration of intranasal Sol-Gel in healthy adults and individuals with schizophrenia.
This study isn't recruiting yet.
In WoolloongabbaSchizophreniaInterventional studyAges 18–64
- Countries
- Australia
- Sponsor
- Metro South Hospital land Health Services
Not Yet RecruitingACTRN12610000387022
Official study titleSocial Cognitive Remediation for Schizophrenia to assess changes in social cognitive ability and symptoms following an individualised training program.
This study isn't recruiting yet.
Location not clearly listedSchizophreniaInterventional studyAges 18–55
- Countries
- Sponsor
- Deakin University
Not Yet RecruitingACTRN12619000723189
Official study titlePilot study to evaluate the effect of a lifestyle intervention: on quality of physical and mental health in people with schizophrenia treated with either clozapine or another antipsychotic medication who are overweight/obese
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Hunter New England Mental Health Local health District
Not Yet RecruitingACTRN12626000530325
Official study titleSchizophrenia Platform for Improving Recovery with Integrated Trials (SPIRIT) – Appendix C: Domain-Specific Appendix GLP-1RA - Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 18–64
- Countries
- Australia
- Sponsor
- University of Queensland
Not Yet RecruitingACTRN12626000583347
Official study titleSchizophrenia Platform for Improving Recovery with Integrated Trials (SPIRIT) - Master Protocol for an adaptive platform trial.
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 18–64
- Countries
- Australia
- Sponsor
- University of Queensland
Not Yet RecruitingACTRN12609000184279
Official study titleTailoring Adjunct Glycine Therapy to Improve Cognitive Function and Clinical Symptoms in Schizophrenia
This study isn't recruiting yet.
Location not clearly listedSchizophreniaInterventional studyAges 18–45
- Countries
- Sponsor
- Alfred Hospital
Not Yet RecruitingACTRN12625000327482
Official study titleRandomised, Controlled Trial to Investigate the Effect of a six-week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Participants Who Had a First-time Treatment Failure on Their First-line Treatment for -Schizophrenia Cohort.
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Lyell McEwin Hospital
RecruitingNCT06071858
Official study titleCluster Randomized Trial of Enhanced Coordinated Specialty Care (CSC 2.0) for Early Psychosis
Multiple locations, including BelmontSchizophrenia, BipolarityBehavioural study
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
RecruitingISRCTN47913690
In United KingdomSchizophreniaResearch studyAges 16–65
- Countries
- United Kingdom
- Sponsor
- Pennine Care NHS Foundation Trust
RecruitingACTRN12621000349842
Official study titleThe effect of Cannabidiol on positive psychotic symptoms in At Risk for psychosis Youth: A randomised controlled trial
In AustraliaSchizophreniaInterventional studyAges 12–25
- Countries
- Australia
- Sponsor
- Orygen
RecruitingISRCTN24746936
In United KingdomSchizophreniaResearch studyAges 16–100
- Countries
- United Kingdom
- Sponsor
- University of Manchester